Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15092135101 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| NeMadipine B | C19H21Cl2NO4 | 79925-38-5 | Details |
| IMpurity A of Falecalcitriol | C27H38F6O3 | 303015-34-1 | Details |
| BAY-M 5579 | C17H18N2O6 | 74936-73-5 | Details |
| Paricalcitol | C27H44O3 | 131918-61-1 | Details |
| 2β-trans-eldecalcitol | C30H50O5 | 861996-34-1 | Details |
| 1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1S)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)- | C27H44O3 | 134523-84-5 | Details |
| Calcitriol | C27H44O3 | 32222-06-3 | Details |
| (1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methyl-6-triethylsilyloxyheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-one | C24H46O2Si | 1101133-55-4 | Details |
| Linagliptin Impurity C | C15H20N6O2 | 1791405-13-4 | Details |
| Calcitriol EP impurity A | C27H44O3 | 73837-24-8 | Details |
| (24R)-paricalcitol | C27H44O3 | 132015-95-3 | Details |
| 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | C30H50O5 | 104121-92-8 | Details |
| Linagliptin iMpurity G | C25H28N8O2 | 668270-11-9 | Details |
| Linagliptin Impurity K | C25H29BrN8O2 | 1638744-06-5 | Details |
| Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C12H18N2O4 | 144689-94-1 | Details |
| Felodipine 3,5-DiMethyl Ester | C17H17Cl2NO4 | 91189-59-2 | Details |
| Linagliptin Impurity F | C27H27F3N8O3 | 1673546-62-7 | Details |
| Dehydro Olmesartan | C24H24N6O2 | 172875-98-8 | Details |
| Alfacalcidol | C30H50O5 | 1217549-27-3 | Details |
| Olmesartan | C24H26N6O3 | 144689-24-7 | Details |
| Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C12H20N2O3 | 144689-93-0 | Details |
| OlmesartanEPImpurityB | C24H24N6O2 | 849206-43-5 | Details |
| Olmesartan Medoxomil Impurity U | C26H30N6O3 | 144689-23-6 | Details |
| Linagliptin N-Acetyl Impurity | C27H30N8O3 | 1803079-49-3 | Details |
| Linagliptin Impurity H | C22H23N7O2 | 1646355-34-1 | Details |
| Linagliptin Impurity JX | C26H28N8O3 | 2137744-33-1 | Details |
| Trityl olmesartan | C48H44N6O6 | 144690-92-6 | Details |
| FALECALCITRIOL | C27H38F6O3 | 83805-11-2 | Details |
| Olmesartan MedoxomiI Impurity C | 87956-26-2 | Details |
| 1H-Indene-1-pentanol, octahydro-4-hydroxy-ε,7a-dimethyl-α,α-bis(trifluoromethyl)-, (εR,1R,3aR,4S,7aR)- | C18H28F6O2 | 2454249-03-5 | Details |
| ethyl 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | C13H13NO3S | 161797-99-5 | Details |
| Olmesartan intermediate impurity IV | C13H22N2O3 | 1092980-84-1 | Details |
| Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | C17H18N2O3S | 923942-34-1 | Details |
| Febuxostat Impurity 8 | C16H17NO4S | 144060-62-8 | Details |
| ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE | C18H21NO4S | 161798-03-4 | Details |
| Febuxostat Descyano Impurity | C15H17NO3S | 1206550-99-3 | Details |
| 4-Hydroxyisophthalonitrile | C8H4N2O | 34133-58-9 | Details |
| Ethyl2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | C18H20N2O3S | 160844-75-7 | Details |
| 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid | C10H16N2O3 | 144690-04-0 | Details |
| Olmesartan Impurity 58 | C12H22N2O2 | 2190488-06-1 | Details |
| 2-[3-(AMinocarbonyl)-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | C16H18N2O4S | 1239233-86-3 | Details |
| 2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | C16H17NO5S | 1239233-87-4 | Details |
| FeBuxostat Impurity 18 | C12H9NO4S | 1312815-35-2 | Details |
| ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate | C15H13NO5S | 2073891-59-3 | Details |
| OlMesartan interMediate iMpurity II | C11H16N2O3 | 144690-07-3 | Details |
| Febuxostat Impurity 6 | C18H22N2O4S | 1271738-74-9 | Details |
| 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid | C12H8N2O3S | 407582-48-3 | Details |
| 4-(4-METHYL-1,3-THIAZOL-2-YL)PHENOL | C10H9NOS | 138330-01-5 | Details |
| Febuxostat Impurity 14 | C15H16N2OS | 1335202-60-2 | Details |
| ethyl 2-(4-(sec-butoxy)-3-formylphenyl)-4-methylthiazole-5- carboxylate | C18H21NO4S | 2375033-31-9 | Details |
| 4-(1-Methylethenyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester | C12H18N2O2 | 157356-73-5 | Details |
| ethyl 2-(4-butoxy-3-formylphenyl)-4-methylthiazole-5- carboxylate | C18H21NO4S | 2230270-03-6 | Details |
| 5-(5-(ethoxycarbonyl)-4-methylthiazol-2-yl)-2-isobutoxybenzoic acid | C18H21NO5S | 2095166-41-7 | Details |
| 5-Thiazolecarboxylic acid, 2-[3-(ethoxycarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl- | C18H21NO5S | 2476465-11-7 | Details |
| 2-(4-HYDROXY-PHENYL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID | C11H9NO3S | 886501-78-6 | Details |
| 4-(1-Hydroxy-1-methylpropyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester | C13H22N2O3 | 172875-53-5 | Details |
| Febuxostat Impurity 7 | C16H18N2O4S | 1350352-70-3 | Details |
| Febuxostat Impurity 130 | C20H25NO5S | 1643131-93-4 | Details |
| 2-(2-Hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester | C13H13NO3S | 118485-48-6 | Details |
| Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
| ethyl 2-(3-carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | C18H22N2O4S | 1346238-15-0 | Details |
| Febuxostat Impurity 32 HCl | C12H11NO3S | 1267681-15-1 | Details |
| Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol) | C15H25NO3 | 754926-25-5 | Details |
| Dehydro Nifedipine N-Oxide | C17H16N2O7 | 88434-69-9 | Details |
| 5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydrop yridine-3-carboxylic acid | C16H16N2O6 | 74936-71-3 | Details |
| Nifedipine | C11H15NO4 | 17438-14-1 | Details |
| vildagliptin Impurity F | C17H24N2O3 | 1789703-36-1 | Details |
| methyl (Z)-2-(2-nitrosobenzylidene)-3-oxobutanoate | C12H11NO5 | 39562-27-1 | Details |
| Vildagliptin IMpurity 2 (Mixture of DiastereoMers) | C24H33N5O3 | 1036959-23-5 | Details |
| Norfloxacin Impurity 6 | C21H15N5O6 | 126192-88-9 | Details |
| diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5- dicarboxylate | C19H22N2O6 | 21829-26-5 | Details |
| Nifedipine Impurity 21 | C19H18N4O6 | 80742-13-8 | Details |
| Salbutamol EP Impurity B | C12H19NO2 | 96948-64-0 | Details |
| Nifedipine Impurity E | C16H17N3O5 | 114709-68-1 | Details |
| DehydroNifedipine | C17H16N2O6 | 67035-22-7 | Details |
| 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-(2-Cyanoethyl) 5-Methyl Ester | C19H19N3O6 | 75130-24-4 | Details |
| 2,6-Dichloro-4,8-dipiperidinopyrimidino[5,4-d]pyrimidine | C16H20Cl2N6 | 7139-02-8 | Details |
| Vildagliptin carboxy acid metabolite | C17H26N2O4 | 565453-40-9 | Details |
| Dipyridamole EP Impurity C | C20H30ClN7O2 | 54093-92-4 | Details |
| Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) | C14H23NO3 | 18910-70-8 | Details |
| vildagliptin Impurity R | C7H8Cl2N2O | 1803168-09-3 | Details |
| m-Nifedipine | C17H18N2O6 | 21881-77-6 | Details |
| Dehydronitrosonifedipine | C17H16N2O5 | 50428-14-3 | Details |
| 4-CHLOROPHTHALIC ACID MONOSODIUM SALT | C8H6ClNaO4 | 56047-23-5 | Details |
| Dipyridamole EP Impurity D | C22H36N8O3 | 1176886-12-6 | Details |
| 3-ethyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate | C18H20N2O6 | 53055-15-5 | Details |
| Nifedipine Impurity 7 | C19H18N4O6 | 80742-11-6 | Details |
| Nimodipine Related Compound B | C21H26N2O8 | 70172-96-2 | Details |
| Nonivamide | C17H27NO3 | 2444-46-4 | Details |
| Dipyridamole EP Impurity F | C21H36N8O5 | 60286-30-8 | Details |
| Nimodipine EP Impurity B | C21H26N2O6 | 21881-78-7 | Details |
| dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate | C17H18N2O6 | 21829-09-4 | Details |
| Dipyridamole EP Impurity B | C23H40N8O6 | 16908-47-7 | Details |
| Dipyridamole EP Impurity A | C25H40N8O2 | 16982-40-4 | Details |
| N-DesMethyl DiphenhydraMine Hydrochloride | C16H20ClNO | 53499-40-4 | Details |
| Nitrendipine EP Impurity C | C19H22N2O6 | 21829-28-7 | Details |
| Vildagliptin (2R)-Isomer | C17H25N3O2 | 1036959-27-9 | Details |
| vildagliptin Impurity C | C17H27N3O3 | 565453-39-6 | Details |
| vildagliptin Impurity E | C17H25N3O2 | 1789703-37-2 | Details |
| Cerium silicide | CeSi2 | 12014-85-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||